The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine
- PMID: 418431
- DOI: 10.1017/s0033291700014318
The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine
Abstract
A blind social assessment at home carried out twice during a year's follow-up of 41 patients on continuation therapy, 21 randomly allocated to pimozide tablets and 20 to fluphenazine decanoate injections. Patients on pimozide were significantly more favourably rated on aspects of sociability, use of leisure, warmth of personal relationships, household tasks and child-rearing. The mode of production of this result is discussed.